SEC Form 4 · accession 0000899243-15-003863
Sorrento Therapeutics, Inc. · SRNE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Henry Ji
Officer — President and CEO · Director
Period of report
Aug 24, 2015
Accepted (ET)
Aug 24, 2015 · 2:31 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000850261
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Aug 24, 2015 | P | 8,888 | $12.843 | A | 17,776 | D | |
| Common StockF1 | holding | — | — | — | 2,053,162 | I | See Footnote |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Shares are held in family trust, of which Dr. Ji is a co-trustee with his wife.